The involvement of GSK3β in bipolar disorder: Integrating evidence from multiple types of genetic studies

J. J. Luykx, M. P.M. Boks, A. P.R. Terwindt, S. Bakker, R. S. Kahn, R. A. Ophoff

Research output: Contribution to journalReview articlepeer-review

27 Scopus citations

Abstract

We aimed to get a comprehensive insight into the genetic evidence supporting the role of GSK3β in bipolar disorder (BD). Using broad searches in NCBI's PubMed and the Genetic Association Database we looked for association, whole-genome linkage, genome-wide association, gene expression, pharmocogenomic, epigenetic, cytogenetic, and mouse model studies performed for BD until July 2009. Per gene, we rated the degree of converging evidence across these types of genetic studies. The genes most consistently associated with BD in the genetic studies we reviewed were GSK3β , GRK3, 5-HTTLPR, GRIN3, COMT, and GLUR3. GSK3β stood out as it was implicated in at least five types of genetic studies. Although our results are limited by design differences of included studies and possibly by publication bias, GSK3β is a plausible candidate gene for BD from a pharmacological and a genetic perspective. Future studies investigating the effects of GSK3β manipulation in BD seem warranted.

Original languageEnglish
Pages (from-to)357-368
Number of pages12
JournalEuropean Neuropsychopharmacology
Volume20
Issue number6
DOIs
StatePublished - Jun 2010
Externally publishedYes

Keywords

  • Bipolar disorder
  • GSK3β
  • Gene
  • Genetics
  • Review

Fingerprint

Dive into the research topics of 'The involvement of GSK3β in bipolar disorder: Integrating evidence from multiple types of genetic studies'. Together they form a unique fingerprint.

Cite this